MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest
Yang Wang et al, 2020, OncoTargets and Therapy CrossRef
Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer Wenjie Zhao et al, 2021, Frontiers in Pharmacology CrossRef
Targeted Chinese Medicine Delivery by A New Family of Biodegradable Pseudo-Protein Nanoparticles for Treating Triple-Negative Breast Cancer: In Vitro and In Vivo Study Hiu Yee Kwan et al, 2021, Frontiers in Oncology CrossRef
Therapeutic effect and metabolic fingerprinting of triple-negative breast cancer cells following exposure to a novel pH-responsive, gambogic acid-loaded micelle Mengting Da et al, 2024, Nanotechnology CrossRef
Unveiling the Potency of Phyto-Constituents to Target TNBC: Mechanism to Therapeutics Sreekumar Usha Devi Aiswarya et al, 2023, Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer CrossRef
Resistance to Intervention: Paclitaxel in Breast Cancer Vipin Mohan Dan et al, 2021, Mini-Reviews in Medicinal Chemistry CrossRef
MiR-1275 Targeting SPARC Promotes Gambogic Acid-Induced Inhibition of Gastric Cancer Ang Cai et al, 2023, Biochemical Genetics CrossRef
Herbal Medicine: Prejudice to Realm of Reality Against TNBC Balachandran S. Vinod et al, 2023, Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer CrossRef
Gambogic Acid Lysinate-induced Cervical Cancer SiHa Cells Apoptosis in vitro and in vivo Jie Niu et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef